Exact Mass: 607.1964

Exact Mass Matches: 607.1964

Found 14 metabolites which its exact mass value is equals to given mass value 607.1964, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-O-Phosphohygromycin

C20H38N3O16P (607.199)

4-O-Phosphohygromycin B

[(1R,2R,3S,4R,6S)-2-[(3R,3aS,4S,4S,5R,6R,6R,7S,7aS)-6-[(1S)-1-amino-2-hydroxyethyl]-3,4,5,7-tetrahydroxy-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-4-yl]oxy-4-amino-3-hydroxy-6-(methylamino)cyclohexyl] dihydrogen phosphate

C20H38N3O16P (607.199)

Geodiamolide J

C28H38BrN3O7 (607.1893)

Asp Ser Glu Glu Glu

C22H33N5O15 (607.1973)

DSEEE

Asp-Ser-Glu-Glu-Glu

C22H33N5O15 (607.1973)

L 768232

C35H35ClNNaO3S (607.1924)

Atopaxar hydrobromide

C29H39BrFN3O5 (607.2057)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent

Montelukast sodium

C35H35ClNNaO3S (607.1924)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D065693 - Cytochrome P-450 Enzyme Inducers > D065694 - Cytochrome P-450 CYP1A2 Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

[(1S,2S,3R,4S,6R)-2-[(3aS,4S,4R,5S,6R,7S,7aS)-6-[(1R)-1-amino-2-hydroxyethyl]-3,4,5,7-tetrahydroxy-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-4-yl]oxy-6-amino-3-hydroxy-4-(methylamino)cyclohexyl] dihydrogen phosphate

[(1S,2S,3R,4S,6R)-2-[(3aS,4S,4R,5S,6R,7S,7aS)-6-[(1R)-1-amino-2-hydroxyethyl]-3,4,5,7-tetrahydroxy-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-4-yl]oxy-6-amino-3-hydroxy-4-(methylamino)cyclohexyl] dihydrogen phosphate

C20H38N3O16P (607.199)

[(2R)-2-[(3S,3aS,4S,4R,6R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-3,4,5,7-tetrahydroxy-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,6-oxane]-2-yl]-2-aminoethyl] dihydrogen phosphate

[(2R)-2-[(3S,3aS,4S,4R,6R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-3,4,5,7-tetrahydroxy-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,6-oxane]-2-yl]-2-aminoethyl] dihydrogen phosphate

C20H38N3O16P (607.199)

7-O-phosphohygromycin B

C20H38N3O16P (607.199)

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[3-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide

C29H32F3N3O6S (607.1964)

(3s,6r,9s,12s,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

C28H38BrN3O7 (607.1893)

(3s,6s,9r,12s,16s,18r)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

C28H38BrN3O7 (607.1893)